Back to all news

Generative AI Outperforms in Lung Adenocarcinoma Grading and Prognosis

EurekAlertResearch
Generative AI Outperforms in Lung Adenocarcinoma Grading and Prognosis

GenAI models demonstrate high accuracy and consistency in pathological grading and risk assessment for lung adenocarcinoma.

Key Details

  • 1Study tested GPT-4o, Claude-3.5-Sonnet, and Gemini-1.5-Pro on 492 digitized slides from public and independent sources.
  • 2Claude-3.5-Sonnet achieved 82.3% accuracy in lung adenocarcinoma grading, with strong repeatability.
  • 3Models extracted 11 histological features and 4 clinical variables for comprehensive risk assessment.
  • 4Diagnostic and prognostic tasks were completed in minutes, much faster than human experts.
  • 5AI models reduced inter-observer variability and enabled objective, standardized analysis across multiple samples.
  • 6GenAI models surfaced new significant prognostic factors including interstitial fibrosis and papillary patterns.

Why It Matters

This breakthrough underscores the transformative potential of generative AI in digital pathology, promising faster, standardized, and potentially more insightful cancer diagnosis and prognosis translation. Such advances could boost accuracy in resource-limited settings and improve reproducibility in pathological assessments, reshaping clinical workflows.

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.